ArticleBiology of reproduction2025
Evaluation of optimal trophoblastic models to mimic uterine vessel remodeling in human pregnancy†.
Article in Biology of reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A perfusable first-generation endometrial microvascular model to study human spiral artery remodeling in pregnancy.Lab on a chip · 2026Article
- Evaluating Maternal Serum SHH Levels in the First Trimester as a Potential Biomarker for Predicting Preeclampsia.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During human pregnancy, a certain proportion of endothelial cells in uterine spiral arteries are replaced by placental extravillous trophoblasts (EVTs). This process is a pivotal step in spiral artery remodeling (SAR), ensuring the adequate supply of oxygen and nutrients to the fetus. Given the ethical constraints and the lack of suitable in vivo animal models, developing ideal in vitro models is crucial for investigating this cellular event. Therefore, it is imperative to evaluate key trophoblastic properties to optimize the in vitro model and replicate the in vivo context of SAR. In this study, we refined a three-dimensional co-culture system involving human trophoblast cells and tubular structure formed by human umbilical vein endothelial cells, allowing for dynamical monitoring of cell behaviors. Using this model, we conducted a comparative analysis of vascular remodeling capabilities among primary EVTs and various trophoblast cell lines. Meanwhile, we examined the expression profiles of multiple SAR-associated genes in trophoblast cells. The correlation between molecular characteristics and vascular remodeling performance was statistically analyzed using a comprehensive scoring system. Our findings highlight the critical roles of EVT-derived NCAM1, ITGB3, ITGAV, and JAG1 in vascular remodeling. Furthermore, JEG-3 and human trophoblast stem cell-derived EVT cells demonstrate significant advantages as optimal models for mimicking primary EVTs in vitro, thereby facilitating investigations into SAR. Consequently, we propose an evaluation framework to assess key attributes of trophoblast cell lines that enable them to accurately represent EVT behaviors in SAR. This study establishes a robust foundation for future exploration of the molecular mechanisms underlying human SAR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.